SEC Form 4
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response. . . . . 0.5 |
1. Name and Address of Reporting Person* Reinhardt, Uwe E. (Last) (First) (Middle) One Boston Scientific Place (Street) Natick, MA 01760-1537 (City) (State) (Zip) USA |
2. Issuer Name and Ticker or Trading Symbol Boston Scientific Corporation (BSX) 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) |
4. Statement for (Month/Day/Year) November 26, 2002 5. If Amendment, Date of Original (Month/Year) |
6. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer Other Officer/Other Description 7. Individual or Joint/Group Filing (Check Applicable Line) X Individual Filing Joint/Group Filing |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr. 3) |
2. Transaction Date (Month/Day/Year) |
3. Transaction Code | V |
4. Securities Acquired (A) or Disposed (D) Of Amount | A/D | Price |
5. Amount of Securities Beneficially Owned at End ofMonth (Instr. 3 and 4) |
6. Owner- ship Form: Direct(D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr. 4) |
Common Stock |
11/26/2002 |
A | |
600 | A | $39.2600 |
|
D |
|
Common Stock |
11/26/2002 |
A | |
1,400 | A | $39.3000 |
4,000 (1) |
D |
|
|
|
|
|
|
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). (over) SEC 1474 (3-99) |
|
Reinhardt, Uwe E. - November 2002 |
Form 4 (continued) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
1. Title of Derivative Security (Instr. 3) |
2. Conver- sion or Exercise Price of Deri- vative Security |
3. Transaction Date (Month/ Day/ Year) |
4. Transaction Code and Voluntary (V) Code (Instr.8) Code | V |
5. Number of Derivative |
6. Date Exercisable(DE) and Expiration Date(ED) (Month/Day/Year) (DE) | (ED) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr.5) |
9. Number of |
10. |
11. Nature of |
Stock Option (Right to Buy) NED |
$24.6800 |
|
|
|
Varies (2) | 05/07/2012 |
Common Stock - 2,000 |
|
2,000 |
D |
|
|
|
|
|
|
|
|
|
|
|
|
Explanation of Responses :
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. |
By: /s/ Lawrence J. Knopf, Attorney-in-fact ________________________________ 12-02-2002 ** Signature of Reporting Person Date Uwe E. Reinhardt, Ph.D. Page 2 SEC 1474 (3-99) |
|
Reinhardt, Uwe E. - November 2002 |
Form 4 (continued) |
FOOTNOTE Descriptions for Boston Scientific Corporation BSX Form 4 - November 2002 Uwe E. Reinhardt One Boston Scientific Place Natick, MA 01760-1537 Explanation of responses: (1) Includes 2,000 shares of restricted stock vesting upon the reporting person's current term of office as a director of the Company. (2) Grant to the reporting person of options to buy 2,000 shares of Common Stock exercisable in annual installments of 667, 667 and 666 shares each on May 7, 2003, 2004 and 2005, the anniversary date of the grant. |
Page 3 |